Evotec and Novo Nordisk form strategic research alliance in diabetes and obesity
- THE ALLIANCE BUILDS UPON EVOTEC?S LEADING DRUG DISCOVERY AND DEVELOPMENT CAPABILITIES IN DIABETES AND RELATED CO-MORBIDITIES
- NOVO NORDISK ACCESSES EVOTEC?S INTEGRATED DISCOVERY AND DEVELOPMENT PLATFORM TO PROGRESS NEW MOLECULES FROM CONCEPT TO IND INCLUDING EVOTEC?S INDIGO PLATFORM